drugset
drugset / Trial / NCT03633760

Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese Population

NCT03633760 ↗

Phase 1 Unknown 24 enrolled A.Menarini Asia-Pacific Holdings Pte Ltd
Non-randomizedSequentialOpen-labelBasic science

Summary

This is a single-dose and multiple-dose, open-label, single-centre pharmacokinetic (PK) study which will be conducted in Phase I Clinical Trial Centre, Chinese University of Hong Kong, to evaluate pharmacokinetics (PK) of different levels of single-dose and multiple-dose of bilastine in healthy Chinese subjects.

Timeline

Start
2018-08-28
Primary completion
2019-04-30
Completion
2019-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bilastine Small molecule 20 mg Oral
Subject Bilastine Small molecule 40 mg Oral

Indications

No indication recorded.